Eyad Kishawi is a medical device entrepreneur, executive, and researcher with three decades of experience developing technology as an engineering leader overseeing the development of novel medical therapeutic and diagnostic technologies involving hardware and software components. He is a seasoned leader with a background in managing the entire product lifecycle, from product creation to acceptance in the marketplace. He specializes in serving as a liaison among advisors, focus groups, investors, board members, and stakeholders. Kishawi is a co-founder and CTO at VydaMed, Inc. VydaMed is a medical device company working on developing a non-invasive closed-loop feedback neuromodulation system that is indicated for regulating anxiety and mood disorders.
Kishawi holds a bachelor’s degree in Electrical Engineering from the University of Massachusetts and a master’s in Biomedical Engineering from CSUS. His electrical engineering work specialized in robotic control systems, and his graduate work specialized in non-parametric and stochastic modeling, and medical instrumentation. Additional educational training includes:
• Emerging Entrepreneurs – Stanford University
• Management Training
• Medical Device Compliance – ISO 13485, ISO 14971, IEC 62304, and QSR
• DSP: Digital Signal Processing on XILINX FPGAs and SIMULINK for DSP design
• Clinical Research, University of Rochester Medical School
• Classification/Artificial Intelligence: Video/Image Compression, Wavelets, Neural Networks, Fuzzy Logic and Chaos
Kishawi was a Research Associate and lecturer at the University of Rochester in New York before starting his medical device technology executive career. In this role, he carried out systems neuroscience research that connected human reflex kinematics with robotic dynamics.
In 1999, Kishawi joined Fox Hollow Technologies in Redwood City, California, as a Principal Biomedical Engineer. He worked on a prominent project that included an image morphology detection system for high-frequency ultrasounds and a wide-band technique designed for use during interventional procedures to identify the acoustic impedance of the tissue.
The following year, Kishawi was appointed by the Mountain View-based NeuroPace as a Principal Biomedical Engineer, where he assumed responsibility for several critical areas, including algorithm design, software development, clinical research, and intraoperative data collection for a deep-brain stimulation device. He went on to develop a chaotic prediction model for epilepsy onset. Kishawi pioneered a unique approach to relating basal ganglion activity to tremor kinematics in patients with Parkinson’s disease. Both epilepsy and Parkinson’s therapies involved the use of closed-loop feedback control systems that are individually trainable.
In 2003, he founded and served as the CEO of BioElectric Solutions, a company that offered value-added modules to companies and universities working on active medical devices. After serving as CEO for three years, Kishawi joined Spinal Modulation as the Director of Electrical and Software Engineering, where he developed a new method for quantifying pain-afferent activity and classifying postures as detected by an implantable neurostimulator. Kishawi published several patents on low-power stimulation, and he drew upon his extensive experience in medical technology and served as a consultant in active diagnostic and therapeutic medical devices.
From 2010-2015, Kishawi served as an R&D Manager at Accuray, heading hardware and firmware development, electromechanical system dynamics design, robotic feedback control systems, and integration. He managed projects in the US, Europe, and Asia, simultaneously, and worked on rebuilding the system from the ground up, introducing two novel technologies and revising three legacy technologies over two years, resulting in a significant expansion of indicated use for the Cyberknife.
In 2015, Kishawi joined ViewRay Incorporated as Director of Systems Engineering, where he headed the development of a treatment delivery control system and scaled up the R&D team consisting of HW, SW, and image processing experts. He managed development programs in California, Ohio, and two locations in Germany. His innovations at ViewRay include developments in ionization chamber design and dose measurements, pulse-to-pulse control of Linac in a magnetic field, and miniaturization and control of Multi-Leaf Collimators.
Kishawi served as Director of R&D- Medical Devices at Abbott for a year and a half, where he headed research and product development activities. The following years after Abbott, Kishawi was the VP of Device Engineering at Profusa and CEO at OSQ, LLC. He co-founded VydaMed in November 2022, a company developing a novel neuromodulation device for treating mood and cognitive disorders.
Kishawi has been granted several patents, including:
• Ion chamber for radiation measurement, patent number: 11224764
• Ion chamber for radiation measurement, patent number: 10821304
• Ion chamber for radiation measurement, patent number: 10183181
• Selective stimulation systems and signal parameters for medical conditions, patent number: 10105541
• Implantable flexible circuit leads and methods of use, patent number: 9919149
• Selective stimulation systems and signal parameters for medical conditions, patent number: 9744360
• Pain management with stimulation subthreshold to paresthesia, patent number: 9468762
• Selective stimulation systems and signal parameters for medical conditions, patent number: 9409021
• Implantable flexible circuit leads and methods of use, patent number: 9314618
• Selective stimulation systems and signal parameters for medical conditions, patent number: 9056197
• Methods, devices, and systems for programming neurostimulation, patent number: 8914128
• Pain management with stimulation subthreshold to paresthesia, patent number: 8380318
• Methods, devices, and systems for programming neurostimulation, patent number: 8249701
• Device and method for non-invasive, localized neural stimulation utilizing the hall effect phenomenon, patent number: 7699768
• Patient-specific template development for neurological event detection, patent number: 7136695